Promising New Type 2 Drug on Horizon

| Nov 16, 2013

A new drug being developed by Eli Lilly Co. that duplicates the effects of a hormone may soon be added to the growing arsenal of pharmaceutical weapons available to treat type 2 diabetes.

The injectable drug, called LY, is designed to mimic the effects of the hormone fibroblast growth factor 21 (FGF21), which is produced by the liver and helps regulate the metabolism of both blood glucose and blood fat (lipids).

Over the course of a month-long trial, 46 patients with type 2 diabetes were injected either with daily doses of the drug at various levels or a placebo. Those who received the highest doses of the drug saw significant improvements in blood fat and cholesterol levels compared to those who received the placebo.

Insulin and blood sugar levels, however, were not significantly impacted, though patients on the higher doses of the drug also lost some weight, researchers said.

"Our current understanding suggests that FGF21 has the ability to favorably affect body weight, partially normalize abnormal lipid levels in patients with diabetes, and has the potential to improve glycemic control," said senior study author Dr. Dave Moller, vice president of endocrinology and cardiovascular research, and clinical investigation for Eli Lilly.

The trial did show the potential for some side effects from the injectable hormone, including allergic reactions as well as immune responses that could cause the drug to lose effectiveness over time.

The study appeared in a September 2013 issue of the journal Cell Metabolism.

 

Click Here To View Or Post Comments

Categories: Eli Lilly, FGF21, Fibroblast Growth Factor 21, LY


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated

Latest Fibroblast Growth Factor 21 Articles

Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.